Strathcona County

FLEXRACK by Qcells and Alltrade Partner on 182 MW Solar Project Portfolio in Canada

Retrieved on: 
Tuesday, October 17, 2023
Partnership, Senior, EPC, Carbon, ERA, Electricity, Natural gas, Marketing, AIES, BEST, Challenge, Oil, Renewable energy, Strathcona County

CLEVELAND, Ohio, Oct. 17, 2023 /PRNewswire/ -- FLEXRACK by Qcells and Alltrade Industrial Contractors Inc., a leading Canadian renewable EPC and construction services company, have partnered on a 182 MW portfolio of solar projects in Canada. The portfolio consists of two fixed tilt, bifacial solar panel projects that are located in Scotford, Alberta and Aldersyde, Alberta. Once complete, the 81 MWp Scotford project will be the largest behind-the-meter solar project in Canada. Additionally, the 101 MWp Saddlebrook project includes the future addition of a flow battery energy storage system, which is one of the first of its kind in North America. The projects are currently under construction and have provided hundreds of local jobs. Both projects will enable fossil fuel companies to reduce greenhouse gas emissions and are expected to complete construction by the fourth quarter of 2023.

Key Points: 
  • CLEVELAND, Ohio, Oct. 17, 2023 /PRNewswire/ -- FLEXRACK by Qcells and Alltrade Industrial Contractors Inc., a leading Canadian renewable EPC and construction services company, have partnered on a 182 MW portfolio of solar projects in Canada.
  • The portfolio consists of two fixed tilt, bifacial solar panel projects that are located in Scotford, Alberta and Aldersyde, Alberta.
  • Once complete, the 81 MWp Scotford project will be the largest behind-the-meter solar project in Canada.
  • Alltrade is constructing the Saddlebrook Solar Project in a joint venture partnership with SkyFire Energy Inc.

Building industry and rental housing providers call for increased focus on purpose-built rentals

Retrieved on: 
Thursday, February 9, 2023
Policy, Strathcona County, Economics, Housing, City, Tax, Interview, Federation, Government, BILD, PBR, Construction, Greater Toronto Area, Human, Ageing, GTA, Property management, Renting, Lease

BILD and FRPO are urging all levels of government to implement policies to stimulate the development of purpose-built rental (PBR) housing to meet rapidly growing demand.

Key Points: 
  • BILD and FRPO are urging all levels of government to implement policies to stimulate the development of purpose-built rental (PBR) housing to meet rapidly growing demand.
  • “Purpose-built rentals represent a vital segment of the GTA and Ontario’s housing stock.
  • The region’s stock of purpose-built rental housing is aging and new supply is coming to market at much lower levels than other forms of housing.
  • “In order to tackle our housing crisis, we need to build much more purpose-built rental housing, faster,” said Tony Irwin, President & CEO of FRPO.

Cancer Support Community Applauds Cancer Moonshot’s Achievements on One-Year Anniversary

Retrieved on: 
Friday, February 3, 2023
Cancer, Strathcona County, Cancer Support Community, Community, Cancer Breakthroughs 2020, Survivor, Caregiver, Social policy of the Joe Biden administration, Patient, Health equity, Hope, White, White House, Organization, CSC, Pharmaceutical industry

WASHINGTON, D.C., Feb. 03, 2023 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC), the world’s largest professionally led nonprofit cancer support network, joins the Biden Administration, cancer patients, survivors, caregivers, and their loved ones in celebrating the one-year anniversary of the reinvigorated Cancer Moonshot, an initiative launched with the goal of cutting the cancer death rate in half over the next 25 years.

Key Points: 
  • WASHINGTON, D.C., Feb. 03, 2023 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC), the world’s largest professionally led nonprofit cancer support network, joins the Biden Administration, cancer patients, survivors, caregivers, and their loved ones in celebrating the one-year anniversary of the reinvigorated Cancer Moonshot, an initiative launched with the goal of cutting the cancer death rate in half over the next 25 years.
  • More than 50 community conversations and events held by the White House and Cancer Cabinet.
  • Over 60 new actions and collaborations from private companies, nonprofits, academic institutions, and patient groups to address cancer prevention, early detection, treatment, care, support, and survivorship.
  • “At CSC, we firmly believe that Community Is Stronger Than Cancer and we are proud to count President Joe Biden, First Lady Dr. Jill Biden, Vice President Kamala Harris, Cancer Moonshot Coordinator Danielle Carnival, Ph.D., and the entire Cancer Moonshot team as members of that Community,” said CSC CEO Debbie Weir.

The Whisler Agency Announces Program That Helps Clients Shift from the Accumulation Phase to the Distribution Phase

Retrieved on: 
Saturday, December 24, 2022
Retirement, Education, Strathcona County, Whisler, Reliability, Risk, Pension fund

Morton, Illinois--(Newsfile Corp. - December 24, 2022) - The Whisler Agency, a Morton, Illinois-based financial services firm, announced its retirement program that protects money from market volatility while focusing on distribution from assets.

Key Points: 
  • Morton, Illinois--(Newsfile Corp. - December 24, 2022) - The Whisler Agency, a Morton, Illinois-based financial services firm, announced its retirement program that protects money from market volatility while focusing on distribution from assets.
  • The program helps protect clients' assets while also focusing on income distribution to provide cash flow after retirement.
  • In their retirement years, retirees will face challenges that can severely impact assets that will be used for income.
  • The Whisler Agency helps retirees identify and mitigate challenges such as market volatility, sequence of returns risk, tax distributions, and survivorship.

AutoNation Wraps Up Year of Giving With Holiday Season Donations to Cancer Organizations

Retrieved on: 
Friday, December 30, 2022
Driscoll Children's Hospital, Hospital, Breast cancer, AutoNation, Patient, Strathcona County, Customer, Prostate cancer, NYSE, Imagine, University, Breast, Transport, Wipe Out Kids Cancer, Blog, Christmas, Buick, Metastasis, Breast Cancer Research Foundation, American Cancer Society, News, J.D. Power, Multimedia, Reputation, BMW, BCRF, ZERO—The End of Prostate Cancer, Moses Austin, Associate, Research, Cancer, Pharmaceutical industry, Toy, Car dealership

FORT LAUDERDALE, Fla., Dec. 30, 2022 /PRNewswire/ -- With its year-round Drive Pink (DRVPNK) mission,  AutoNation, Inc. (NYSE: AN) has proudly surpassed $35 million raised to help drive out cancer. Associates from coast to coast wrapped up 2022 with a flurry of initiatives to benefit children and adults whose lives have been impacted by cancer.

Key Points: 
  • Associates from coast to coast wrapped up 2022 with a flurry of initiatives to benefit children and adults whose lives have been impacted by cancer.
  • In 2022, AutoNation Customers generously donated nearly $800,000 through AutoNation's Credit Card Donation Program, with 100 percent of proceeds directly benefiting this year's national DRVPNK charity partners: American Cancer Society, Zero – The End of Prostate Cancer, National Pediatric Cancer Foundation and the Breast Cancer Research Foundation (BCRF).
  • Since 2013, AutoNation has contributed over $35 million to its extensive network of charitable community partners in support of cancer research across the spectrum, from pediatric cancer to treatments for prostate cancer and more.
  • Through its bold leadership and brand affinity, the AutoNation Brand is synonymous with "DRVPNK" and "What Drives You, Drives Us."

New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival

Retrieved on: 
Thursday, December 15, 2022
Lymphedema, IPD, ASX, Kaplan–Meier estimator, Poster, Risk, Cleveland Clinic, Skin, HIV Prevention Trials Network, Patient, Heart failure, Radiation, BIS, Research, Progression-free survival, Breast cancer, FDA, Strathcona County, Quality of life, Multimedia, Radiation therapy, Human, Lymphatic system, Swelling, Medical imaging

CARLSBAD, Calif., Dec. 15, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) is pleased to announce a poster showing that breast cancer patients receiving early detection of lymphedema using ImpediMed's L-Dex technology and intervention had statistically higher rates of lymphedema progression-free survival through three years compared to using tape measure was presented at the 2022 San Antonio Breast Cancer Symposium on December 6-10, 2022 in San Antonio, Texas.

Key Points: 
  • CARLSBAD, Calif., Dec. 15, 2022 /PRNewswire/ -- ImpediMed Limited (ASX: IPD) is pleased to announce a poster showing that breast cancer patients receiving early detection of lymphedema using ImpediMed's L-Dex technology and intervention had statistically higher rates of lymphedema progression-free survival through three years compared to using tape measure was presented at the 2022 San Antonio Breast Cancer Symposium on December 6-10, 2022 in San Antonio, Texas.
  • The poster, titled "Bioimpedance spectroscopy monitoring reduces long-term clinical lymphedema risk" includes a Kaplan-Meier analysis of data from the PREVENT Trial to assess lymphedema progression-free survival in breast cancer patients who triggered for subclinical lymphedema and received intervention (n=209).
  • The analysis showed that there were statistically higher rates of lymphedema progression-free survival in patients screened for subclinical lymphedema using L-Dex compared to using tape measure, p = 0.021.
  • He continued, "Chronic lymphedema is a serious side effect of breast cancer treatment that dramatically impacts patients' quality of life in survivorship.

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Focuses on Resources for Children's Cancers

Retrieved on: 
Thursday, December 15, 2022
Research, Health, CHAI, Cervical cancer, Survival rate, NCCN, ACC, Policy, Breast, United, Childhood cancer, FACP, DAR, Smoking cessation, American Cancer Society, St. Jude Children's Research Hospital, National Comprehensive Cancer Network, Hospital, Burkitt lymphoma, Journal of the National Comprehensive Cancer Network, Learning, Prostate, ACS, Education, Virtual, Parirenyatwa Hospital, GICC, Chair, Patient, Cancer pain, Incidence, Acute lymphoblastic leukemia, Strathcona County, Global Initiative, Organization, Medical device, Dietary supplement, Medicine, Gum arabic, MD, Developing country, Cancer

DAR ES SALAAM, Tanzania and PLYMOUTH MEETING, Pa., Dec. 15, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is working on new NCCN Harmonized Guidelines™ for Sub-Saharan Africa, in collaboration with the African Cancer Coalition (ACC), the American Cancer Society (ACS), and the Clinton Health Access Initiative (CHAI). The organizations are part of Allied Against Cancer, a global multi-sector effort to improve resource-stratified access to life-saving cancer care in Sub-Saharan Africa. These harmonized guidelines build on the successful implementation of evidence-based, expert consensus context-appropriate recommendations for managing nearly all adult cancers across more than a dozen countries throughout the region. The groups recently reunited in Dar es Salaam, Tanzania to launch four additional NCCN Harmonized Guidelines™ specifically focused on best practices for treating children with cancer.

Key Points: 
  • The organizations are part of Allied Against Cancer, a global multi-sector effort to improve resource-stratified access to life-saving cancer care in Sub-Saharan Africa.
  • NCCN Harmonized Guidelines use color-coded recommendations for optimal cancer care in high-resource settings alongside pragmatic modifications for effective treatment options in low- and mid-resource settings.
  • The National Comprehensive Cancer Network ( NCCN ) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education.
  • NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives.

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Focuses on Resources for Children's Cancers

Retrieved on: 
Thursday, December 15, 2022
Research, Health, CHAI, Cervical cancer, Survival rate, NCCN, ACC, Policy, Breast, United, Childhood cancer, FACP, DAR, Smoking cessation, American Cancer Society, St. Jude Children's Research Hospital, National Comprehensive Cancer Network, Hospital, Burkitt lymphoma, Journal of the National Comprehensive Cancer Network, Learning, Prostate, ACS, Education, Virtual, Parirenyatwa Hospital, GICC, Chair, Patient, Cancer pain, Incidence, Acute lymphoblastic leukemia, Strathcona County, Global Initiative, Organization, Medical device, Dietary supplement, Medicine, Gum arabic, MD, Developing country, Cancer

DAR ES SALAAM, Tanzania and PLYMOUTH MEETING, Pa., Dec. 15, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is working on new NCCN Harmonized Guidelines™ for Sub-Saharan Africa, in collaboration with the African Cancer Coalition (ACC), the American Cancer Society (ACS), and the Clinton Health Access Initiative (CHAI). The organizations are part of Allied Against Cancer, a global multi-sector effort to improve resource-stratified access to life-saving cancer care in Sub-Saharan Africa. These harmonized guidelines build on the successful implementation of evidence-based, expert consensus context-appropriate recommendations for managing nearly all adult cancers across more than a dozen countries throughout the region. The groups recently reunited in Dar es Salaam, Tanzania to launch four additional NCCN Harmonized Guidelines™ specifically focused on best practices for treating children with cancer.

Key Points: 
  • The organizations are part of Allied Against Cancer, a global multi-sector effort to improve resource-stratified access to life-saving cancer care in Sub-Saharan Africa.
  • NCCN Harmonized Guidelines use color-coded recommendations for optimal cancer care in high-resource settings alongside pragmatic modifications for effective treatment options in low- and mid-resource settings.
  • The National Comprehensive Cancer Network ( NCCN ) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education.
  • NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives.

THE PROSTATE CANCER FOUNDATION AND ZERO - THE END OF PROSTATE CANCER ANNOUNCE 2022 YOUNG INVESTIGATOR AWARD

Retrieved on: 
Wednesday, December 14, 2022
Samuel Oschin, Physician, PCF, MD, Metastasis, Better Business Bureau, Cedars-Sinai Medical Center, Patient, Prostate Cancer Foundation, Research, Death, Charity Navigator, Disease, MCRPC, Strathcona County, Quality of life, Health equity, Systemic, Veteran, Prostate cancer, Education, ZERO, Medical imaging, Pharmaceutical industry, Black

LOS ANGELES, Dec. 14, 2022 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and ZERO today announced the 2022 ZERO-PCF VAlor Young Investigator Award for innovative research into the causes of racial disparities in prostate cancer and potential strategies to reduce them.

Key Points: 
  • LOS ANGELES, Dec. 14, 2022 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and ZERO today announced the 2022 ZERO-PCF VAlor Young Investigator Award for innovative research into the causes of racial disparities in prostate cancer and potential strategies to reduce them.
  • "We can't end prostate cancer without eliminating the long-standing disparities in prostate cancer," says Jamie Bearse, ZERO's CEO and President.
  • The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization dedicated to funding life-saving prostate cancer research.
  • ZERO The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted.

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

Retrieved on: 
Monday, December 12, 2022
Oncology, Associate professor, Fox Chase Cancer Center, Prostate, Health, Cancer, Professor, Neoplasm, NCCN, Policy, Patient, Associate, SCM, City, Pharmacist, Wilms' tumor, Pharmacology, Fatigue, Duke Cancer Institute, University of Michigan Rogel Cancer Center, Bioethics, MPH, University, National Comprehensive Cancer Network, Dizziness, MD Anderson Cancer Center, Overalls, NETS, Education, MBA, Harborside, Report, Hematology, JD, Chair, Internal medicine, Haematopoietic system, City of Hope, Communication, Duke University Hospital, Mayo Clinic Cancer Center, UCSF, Strathcona County, Survival, Caregiver, UCSF Helen Diller Family Comprehensive Cancer Center, Life expectancy, Public policy, Medical imaging, Pharmaceutical industry, Research, Epidemiology, MD, Medicine, Hope, UAB, Doctor of Philosophy

PLYMOUTH MEETING, Pa., Dec. 12, 2022 /PRNewswire/ -- New research from cancer research and treatment organization City of Hope in the December 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds that only 30% of patients with advanced neuroendocrine tumors (NETs) say their top goal for treatment is living longer. The remaining patients selected other single specific treatment goals as most important, such as maintaining the ability to do daily activities, reducing or eliminating pain, or reducing or eliminating symptoms like fatigue. 66.7% of those surveyed agreed with the statement: "I would rather live a shorter life than lose my ability to take care of myself."

Key Points: 
  • However, respondents felt their doctors were more singularly focused on extending overall survival, even if it impacted other outcomes.
  • Only 51.7% of patients perceived that they had the same treatment goals as their physician.
  • Complimentary access to " Patient-Defined Goals and Preferences Among Adults With Advanced Neuroendocrine Tumors " is available until March 10, 2023.
  • The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .